Wolverine Trading, LLC Novartis Ag Transaction History

Wolverine Trading, LLC

$133 Billion
Q3 2025

A detailed history of Wolverine Trading, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wolverine Trading, LLC holds 4,415 shares of NVS stock, worth $580,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,415

Previous 9,476 53.41%

Holding current value

$580,793

Previous $1.15 Million 50.61%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$113.5 - $129.73 $574,423 - $656,563	-5,061 Reduced 53.41%	4,415 $566,000
Q2 2025 Aug 18, 2025	BUY	$101.96 - $121.01 $155,183 - $184,177	1,522 Added 19.14%	9,476 $1.15 Million
Q1 2025 May 15, 2025	SELL	$97.14 - $115.57 $1.55 Million - $1.85 Million	-15,982 Reduced 66.77%	7,954 $886,000
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $1.54 Million - $1.87 Million	15,928 Added 198.9%	23,936 $2.33 Million
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $849,889 - $968,087	8,008 New	8,008 $921,000

Q2 2023 Aug 23, 2023	SELL	$92.52 - $104.91 $120,831 - $137,012	-1,306 Reduced 12.89%	8,823 $890,000
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $810,623 - $940,072	10,129 New	10,129 $928,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $1.43 Million - $1.62 Million	-17,844 Reduced 72.41%	6,800 $598,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $1.96 Million - $2.17 Million	24,644 New	24,644 $2.16 Million
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $209,093 - $230,949	-2,453 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $204,825 - $241,546	2,453 New	2,453 $213,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $887,358 - $983,073	-10,803 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $64,501 - $72,606	797 Added 7.97%	10,803 $943,000
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $351,088 - $491,881	-4,968 Reduced 33.18%	10,006 $819,000
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $1.03 Million - $1.16 Million	-12,173 Reduced 44.84%	14,974 $1.42 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $2.36 Million - $2.6 Million	-27,565 Reduced 50.38%	27,147 $2.37 Million
Q2 2019 Aug 20, 2019	BUY	$75.4 - $92.8 $3.55 Million - $4.37 Million	47,087 Added 617.53%	54,712 $5 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $324,553 - $371,220	4,309 Added 129.95%	7,625 $733,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $44,269 - $49,294	-601 Reduced 15.34%	3,316 $283,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $262,203 - $303,293	3,917 New	3,917 $337,000
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $240,241 - $287,203	-3,413 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $246,862 - $264,985	3,413	3,413 $287,000

Others Institutions Holding NVS

# of Institutions

1,601

Shares Held

137M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Novartis Ag Transaction History